Cite
冠心病患者血清CXCR3、CXCL5、CXCL12水平与冠脉病变程度和预后的关系研究.
MLA
杨春, et al. “冠心病患者血清CXCR3、CXCL5、CXCL12水平与冠脉病变程度和预后的关系研究.” Progress in Modern Biomedicine, vol. 21, no. 24, Dec. 2021, pp. 4713–18. EBSCOhost, https://doi.org/10.13241/j.cnki.pmb.2021.24.023.
APA
杨春, 殷宇岗, 徐恒, 郭华, 李瑶, & 吕磊. (2021). 冠心病患者血清CXCR3、CXCL5、CXCL12水平与冠脉病变程度和预后的关系研究. Progress in Modern Biomedicine, 21(24), 4713–4718. https://doi.org/10.13241/j.cnki.pmb.2021.24.023
Chicago
杨春, 殷宇岗, 徐恒, 郭华, 李瑶, and 吕磊. 2021. “冠心病患者血清CXCR3、CXCL5、CXCL12水平与冠脉病变程度和预后的关系研究.” Progress in Modern Biomedicine 21 (24): 4713–18. doi:10.13241/j.cnki.pmb.2021.24.023.